Gwen Melincoff
Direttore/Membro del Consiglio presso GAIN THERAPEUTICS, INC.
Patrimonio netto: 461 901 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Gwen Melincoff
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA
31
| Subsidiary | Pharmaceuticals: Major | 31 |
| Public Company | Pharmaceuticals: Major | 28 | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA.
19
| Subsidiary | Biotechnology | 19 |
| Public Company | Pharmaceuticals: Major | 19 | |
| Public Company | Pharmaceuticals: Major | 18 | |
| Subsidiary | Pharmaceuticals: Major | 16 | |
| Public Company | Biotechnology | 15 | |
| Public Company | Medical Specialties | 13 | |
12
| Public Company | Biotechnology | 12 |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania.
1
| Subsidiary | Investment Managers | 1 |
Vodia Capital LLC
 Vodia Capital LLC Investment ManagersFinance Part of Robertson Stephens Wealth Management LLC, Vodia Capital LLC provides investment advisory services. The company is based in Concord, MA. The company was founded by David B. Matias. David B. Matias has been the CEO since incorporation. Vodia Capital was acquired by Robertson Stephens Wealth Management LLC on December 13, 2022.
1
| Subsidiary | Investment Managers | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Gwen Melincoff tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| The Hebrew University of Jerusalem | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Masters Business Admin Graduate Degree Masters Business Admin Doctorate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Doctorate Degree Masters Business Admin Graduate Degree | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Technion-Israel Institute of Technology | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| The College of Management Academic Studies | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Protalix Ltd. | Founder Chairman Director/Board Member Director/Board Member | ||
| Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chairman Corporate Officer/Principal | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chairman Director/Board Member Chief Executive Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer General Counsel Director of Finance/CFO | |
| XENOPORT, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Sales & Marketing General Counsel | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
| MEDIWOUND LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Sales & Marketing Sales & Marketing | |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| ADYNXX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member President | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SOL-GEL TECHNOLOGIES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 35 |
| Israele | 12 |
| Svizzera | 4 |
| Norvegia | 2 |
| Francia | 2 |
Settori
| Health Technology | 36 |
| Consumer Services | 10 |
| Finance | 4 |
| Commercial Services | 2 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 677 |
| Independent Dir/Board Member | 206 |
| Corporate Officer/Principal | 206 |
| Chairman | 185 |
| Chief Executive Officer | 152 |
Contatti più connessi
| Insiders | |
|---|---|
| Eckard Weber | 46 |
| Zeev Bronfeld | 46 |
| Pierre Legault | 45 |
| Ernest Mario | 44 |
| Patrick Heron | 42 |
| John Freund | 37 |
| Eliot Forster | 35 |
| Mahendra Shah | 34 |
| Jan Hendrik Egberts | 33 |
| Ambrose Bailey | 32 |
| Aharon Schwartz | 29 |
| Khalid Islam | 29 |
| Bruce Peacock | 28 |
| Dov Goldstein | 28 |
| Hans-Peter Hasler | 28 |
- Borsa valori
- Insiders
- Gwen Melincoff
- Connessioni Società
